Travel-related Schistosomiasis Acquired in Laos by Leshem, Eyal et al.
Travel-related 
Schistosomiasis 
Acquired in Laos
Eyal Leshem, Eyal Meltzer, Esther Marva, 
and Eli Schwartz
Twelve Israeli travelers acquired schistosomiasis in 
Laos during 2002–2008, and 7 of them had acute schisto-
somiasis. The patients were probably exposed to Schisto-
soma mekongi in southern Laos, an area known to be en-
demic for schistosomiasis. Four possibly were infected in 
northern Laos, where reports of schistosomiasis are rare.
S
chistosomiasis is a widely distributed intravascular 
trematode infection. Estimates indicate that >200 mil-
lion people are infected with schistosomiasis, mainly in Af-
rica. In Asia, 3 Schistosoma species cause human infection: 
S. japonicum, S. malayensis, and S. mekongi. S. mekongi 
endemicity is thought to be limited to a 200-km area of 
the Mekong River Basin, stretching from the southern tip 
of Laos to Cambodia (Figure) (1). However, this parasite’s 
intermediary host, freshwater snails (Neotricula aperta), 
has recently been found to be more widespread and to be 
advancing northwards (1,2). Attwood has suggested that S. 
mekongi may extend as far north as Khammouane Province 
in southern Laos (Figure) (1,3).
Acute schistosomiasis is a transient hypersensitivity 
reaction associated with tissue migration of Schistosoma 
spp. larvae in nonimmune persons. This syndrome is char-
acterized by fever, cough, fatigue, myalgia, urticaria, and 
gastrointestinal complaints. Although acute schistosmiasis 
caused by S. japonicum was extensively studied long ago 
(4), we found no reports of acute schistosmiasis caused by 
S. mekongi. Moreover, current literature states that acute 
schistosmiasis has never been described as a feature of S. 
mekongi infection (5).
The Study
The study was conducted at the Center for Geo-
graphic Medicine at Sheba Medical Center and was ap-
proved by the institutional review board. Travel-related 
schistosomiasis was deﬁ  ned as a case of schistosomiasis 
conﬁ  rmed by serology or ova detection in a traveler who 
had been exposed to freshwater in Laos. Travelers were
thoroughly questioned regarding freshwater exposures 
during the index trip and any previous trips to schistoso-
miasis-endemic areas.
Serologic diagnosis conducted at the Israel Ministry 
of Health (MOH) Central Laboratories in Jerusalem was 
based on the soluble egg antigen ELISA test (IVD Re-
search Inc., Carlsbad, CA, USA), a nonspecies-speciﬁ  c 
method. Consequently, most samples (11/12) were sent to 
the US Centers for Disease Control and Prevention (CDC) 
for species-speciﬁ  c serologic assays (Falcon Assay Screen-
ing Test ELISA [FAST-ELISA], CDC, Atlanta, GA, USA) 
(6). This method is used for S. japonicum serodiagnosis; 
speciﬁ  c serology for S. mekongi is unavailable.
Stool specimens were tested for the presence of Schis-
tosoma spp. ova (merthiolate–iodine-formaldehyde tech-
nique) at the Israel MOH and Clalit Health Services labora-
tories. Fisher exact test was used for categoric data and the 
Student t test for continuous data. Statistical signiﬁ  cance 
was set at p<0.05.
During 2002–2008, 12 patients (5 male, 7 female [2 
children]) had travel-related schistosomiasis acquired in 
Laos (Table 1). No freshwater exposures in Schistosoma-
endemic areas in Asia (excluding the index trip to Laos) 
were reported by patients (Table 1).
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Figure. Map of Laos. The area in which Schistosoma mekongi 
is known to be endemic is highlighted in light blue. The area 
highlighted in light yellow shows both the known area and the area 
predicted by Attwood’s paleogeographic models (1) to be inhabited 
by Neotricula aperta (freshwater snails), the known intermediary 
host for S. mekongi. Two foci of travel-related schistosomiasis are 
also highlighted with red stars. The dark blue line shows the route 
of the Mekong River.Mean patient age was 24 years (range, 6–42 years). 
Seven patients were exposed to freshwater in both south-
ern and northern Laos (4,000 Islands and the town of Vang 
Vieng, respectively); 1 patient was exposed only in south-
ern Laos (Figure). Notably, 4 patients reported freshwa-
ter exposure exclusively in northern Laos (Vang Vieng). 
Three of the 4 reported no travel in southern Laos; 1 patient 
(Table 1, patient 10) visited southern Laos but was not ex-
posed to freshwater. Exposure occurred during the months 
of February–April for 9 of the 12 patients.
Seven patients had a diagnosis of acute schistosmiasis. 
Fever (86%), headache (86%), urticarial rash (71%), and 
cough (71%) were the most prevalent acute schistosmiasis 
symptoms (Table 2). Four patients reported chronic gas-
trointestinal symptoms (abdominal pain and discomfort, 
diarrhea or loose stools). One patient described a pruritic 
papular rash that appeared hours after exposure and re-
solved within a few days (suspected cercarial dermatitis). 
The patient was asymptomatic upon evaluation at our clinic 
(Table 1, patient 12).
Diagnosis was made by positive serology in all 12 pa-
tients. Eleven serum samples were sent to CDC for specia-
tion; 9 patients had positive immunoblots for S. japonicum 
(Table 1). One patient had a positive immunoblot for S. 
haematobium; this result was judged to be a cross-reaction 
because the patient had never visited S. haematobium–en-
demic areas.
S. mekongi/japonicum ova were detected in stool 
samples of 1 of 7 patients who submitted such samples for 
ova detection (Table 1). Issues of technical proﬁ  ciency and 
expertise precluded a deﬁ  nite conclusion regarding specia-
tion according to egg size. Laboratory ﬁ  ndings in 5 patients 
with acute schistosmiasis were signiﬁ  cant for marked eo-
sinophilia (Table 2).
All infected patients were treated with praziquantel at 
>12 weeks postexposure to avoid treatment failure (8). Of 
the acute schistosmiasis patients, 3 of the 7 required corti-
costeroid treatment during the acute illness.
Conclusions
Acute schistosmiasis, which is considered to be a hy-
persensitivity reaction that usually develops a few weeks 
after Schistosoma infection, is best studied in nonimmune 
travelers rather than in continuously exposed local popula-
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Table 1. Demographic, epidemiologic, and clinical characteristics of travelers with schistosomiasis acquired in Laos* 
Patient
no.
Age,
y/sex
Clinical
features
Countries visited 
during index trip
Places of water 
exposure in 
Laos
Date of 
exposure
Date of 
clinic visit
Possible past 
exposure to 
schistosomiasis
Serology, 
genus-specific/
immunoblot
Stool
ova
1 27/F AS China, Laos, 
Cambodia,
Thailand
4,000 Islands 2003 Apr 2003 Sep 1997, Malawi Pos/S.
japonicum
Neg
2 22/F AS Thailand, Laos, 
Cambodia,
Vietnam
Vang Vieng, 
4,000 Islands
2007 Jun 2007 Aug No Pos/S.
japonicum
Neg
3 23/M AS Thailand, Nepal, 
Laos, Vietnam, 
Cambodia
Vang Vieng, 
4,000 Islands
2006 Apr 2006 Jun No Pos/S.
japonicum
ND
4 38/F AS India, Thailand, 
Laos, Cambodia
Vang Vieng, 
4,000 Islands
2008 Apr 2008 May No Pos/S.
japonicum
Neg
5 9/F AS India, Thailand, 
Laos, Cambodia
Vang Vieng, 
4,000 Islands
2008 Apr 2008 May No Pos/S.
japonicum
Pos
6 42/M AS India, Thailand, 
Laos, Cambodia
Vang Vieng, 
4,000 Islands
2008 Apr 2008 May No Pos/S.
japonicum
ND
7 6/M AS India, Thailand, 
Laos, Cambodia
Vang Vieng, 
4,000 Islands
2008 Apr 2008 May No Pos/S.
japonicum
ND
8 24/F CS Thailand, Laos, 
India
Vang Vieng, 
4000 Islands
2003 Nov 2006 May No Pos/Neg Neg
9 36/F CS India, Thailand, 
Vietnam,
Cambodia, Laos
Vang Vieng 2004 Mar 2005 May No Pos/S.
japonicum
ND
10 26/F CS Thailand, Laos, 
Australia, New 
Zealand
Vang Vieng 2003 Nov 2004 Nov No Pos/S.
haematobium†
Neg
11 22/M CS Thailand, Laos, 
China, Nepal
Vang Vieng 2007 Feb 2007 Dec No Pos/ND Neg
12 23/M CDA Thailand, Laos, 
Vietnam,
Cambodia, China
Vang Vieng 2007 Mar 2007 Aug No Pos/S.
japonicum
ND
*AS, acute schistosomiasis; CS, chronic schistosomiasis; pos, positive; neg, negative; ND, not done; S. japonicum, Schistosoma japonicum; S.
hematobium, Schistosoma haematobium; CDA, cercarial dermatitis, asymptomatic. 
†Patient tested positive on S. haematobium immunoblot.  Travel-Related Schistosomiasis Acquired in Laos
tions. We report 7 cases of acute schistosmiasis presumably 
caused by S. mekongi infection acquired in Laos. Acute 
schistosmiasis is reportedly not a species-speciﬁ  c phenom-
enon but may develop after infection with any Schistosoma 
spp. (8), a view strengthened by this report.
Symptoms of acute schistosmiasis caused by S. me-
kongi, although a small number of cases, appear similar to 
symptoms of acute schistosmiasis caused by S. mansoni or 
S. haematobium (7) (Table 2). The only symptom signiﬁ  -
cantly more prevalent in acute schistosmiasis caused by S. 
mekongi was headache. 
Most Schistosoma infections in travelers are acquired 
in Africa (8,9). In our clinic, travel-related schistosomia-
sis acquired outside Africa was diagnosed only in travel-
ers exposed in Laos (8). This exposure is probably due to 
the popularity of water-related adventure activities among 
travelers to Laos. 
S. mekongi–endemic areas in Laos have presumably in-
cluded only the southern reaches of the Mekong River (Fig-
ure) (1,2,5). However, this assumption may reﬂ  ect a ser-
endipitous effect because schistosomiasis in Laos was ﬁ  rst 
diagnosed in immigrants originating from this region. These 
early schistosomiasis cases led early epidemiologic surveys 
to the region of Khong, where most subsequent studies were 
performed (5,10). Since these epidemiologic surveys were 
conducted, S. mekongi infections acquired in northern Laos 
have been described only anecdotally (11–13). 
In this report, we describe 4 patients with schistoso-
miasis apparently acquired in northern Laos (Figure) after 
exposure to freshwater exclusively in Vang Vieng; that is, 
they reported no other freshwater exposure during their 
visit to Laos. However, because of lack of species-speciﬁ  c 
serology and the inability to ﬁ  nd Schistosoma ova in these 
patients’ stool samples, we can not determine which Schis-
tosoma spp. caused their infection.
Most of these patients were infected during February–
April, Mekong’s early low-water period, indicating a sea-
sonal infection pattern similar to that of local populations 
(5). The increased risk of schistosomiasis during the late 
dry season should be conveyed to travelers during pretravel 
consultations.
Our observation of Schistosoma infection in the 4 
travelers exposed exclusively in Vang Vieng has several 
limitations. First, the diagnosis was based on positive se-
rology and not on ova detection. Cross-reactivity of nonhu-
man Schistosoma spp. with S. japonicum in serologic stud-
ies (e.g., S. sinensium or S. ovuncatum) could have caused 
seropositivity in our patients. Second, these 4 travelers 
(Table 1, patients 9–12) have visited other areas in Asia 
known to be Schistosoma endemic (China) or suspected to 
be (Vietnam, Nepal). Although travelers were thoroughly 
questioned regarding possible freshwater exposures, they 
may not have recalled minor exposures. Finally, we found 
no published malacologic surveys of the Vang Vieng area, 
and most experts regard this area as free from N. aperta, the 
intermediate host of S. mekongi.
In other world regions (e.g., Lake Malawi in Africa), 
Schistosoma-infected travelers have served as sentinels 
alerting local authorities to previously unsuspected foci of 
transmission (14). The cases of schistosomiasis in travel-
ers thought to be exposed only in northern Laos, an area 
where dam building may have changed local conditions, 
mandates a systematic revaluation of S. mekongi distribu-
tion in Laos.
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Clinical characteristic 
Infections
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case-patients in 
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